Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mamon

Showing results (51-60 of 101) with videos related to

Pageof 11
Sort By:
International Journal of Radiation Oncology, Biology, Physics|March 8, 2011
Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and olderDanielle N Margalit, Harvey J Mamon, Marek Ancukiewicz, et al.
Molecular and Clinical Oncology|May 27, 2020
Definitive re-irradiation of locally recurrent esophageal cancer after trimodality therapy in patients with a poor performance statusDaniel W Kim, Sana Raoof, Nayan Lamba, et al.
Cancer|February 19, 2010
Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancerRonald C Chen, Harvey J Mamon, Yu-Hui Chen, et al.
Cancer|June 10, 2011
A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003Harvey J Mamon, Donna Niedzwiecki, Donna Hollis, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2009
Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or olderDavid T Miyamoto, Harvey J Mamon, David P Ryan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2012
Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancerRonald C Chen, Harvey J Mamon, Marek Ancukiewicz, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 6, 2017
A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancerN N Sanford, P J Catalano, P C Enzinger, et al.
Clinical and Translational Radiation Oncology|August 1, 2022
Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancerShing Fung Lee, Pui Lam Yip, Aray Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction CancerAbraham J Wu, Walter R Bosch, Daniel T Chang, et al.
American Journal of Clinical Oncology|March 1, 2014
The Impact of Positive Margins on Outcome Among Patients With Gastric Cancer Treated With RadiationJonathan D Schoenfeld, Jennifer Y Wo, Harvey J Mamon, et al.
Pageof 11

Showing results (51-60 of 101) with videos related to

Sort By:
Pageof 11
International Journal of Radiation Oncology, Biology, Physics|March 8, 2011
Tolerability of combined modality therapy for rectal cancer in elderly patients aged 75 years and olderDanielle N Margalit, Harvey J Mamon, Marek Ancukiewicz, et al.
Molecular and Clinical Oncology|May 27, 2020
Definitive re-irradiation of locally recurrent esophageal cancer after trimodality therapy in patients with a poor performance statusDaniel W Kim, Sana Raoof, Nayan Lamba, et al.
Cancer|February 19, 2010
Patient-reported acute gastrointestinal symptoms during concurrent chemoradiation treatment for rectal cancerRonald C Chen, Harvey J Mamon, Yu-Hui Chen, et al.
Cancer|June 10, 2011
A phase 2 trial of gemcitabine, 5-fluorouracil, and radiation therapy in locally advanced nonmetastatic pancreatic adenocarcinoma : cancer and Leukemia Group B (CALGB) 80003Harvey J Mamon, Donna Niedzwiecki, Donna Hollis, et al.
International Journal of Radiation Oncology, Biology, Physics|October 6, 2009
Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or olderDavid T Miyamoto, Harvey J Mamon, David P Ryan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 23, 2012
Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancerRonald C Chen, Harvey J Mamon, Marek Ancukiewicz, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|May 6, 2017
A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced esophageal cancerN N Sanford, P J Catalano, P C Enzinger, et al.
Clinical and Translational Radiation Oncology|August 1, 2022
Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancerShing Fung Lee, Pui Lam Yip, Aray Wong, et al.
International Journal of Radiation Oncology, Biology, Physics|June 25, 2015
Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction CancerAbraham J Wu, Walter R Bosch, Daniel T Chang, et al.
American Journal of Clinical Oncology|March 1, 2014
The Impact of Positive Margins on Outcome Among Patients With Gastric Cancer Treated With RadiationJonathan D Schoenfeld, Jennifer Y Wo, Harvey J Mamon, et al.
Pageof 11